Search

everythinglearnresearchcommunity

for

Search:↓

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

Understanding keratinization is crucial for treating skin conditions like ichthyoses and psoriasis.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

Resistance exercise can reduce muscle protein issues caused by finasteride.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Hair proteins in preschool children and their mothers could indicate developmental changes and health status.

Bioassays help find useful compounds in nature for making medicines, supplements, and cosmetics.

Iron deficiency is the main cause of hair loss in women, and iron supplements started within 6 months can improve hair health.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Certain genes are more active during wound healing in axolotl and Acomys, which could help develop materials that improve human wound healing and regeneration.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Dutasteride and finasteride affect different cell types differently.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.